Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05980130
Other study ID # 23.0150
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 15, 2023
Est. completion date August 31, 2026

Study information

Verified date October 2023
Source University of Louisville
Contact Patrick Possel, Dr.rer.soc.
Phone 502-852-0623
Email patrick.possel@louisville.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Many people know that a poor diet, exercise, smoking, and alcohol use cause heart disease. However, a less known factor that increases the risk of heart disease is depression. In addition, heart disease can also make depression worse. Almost half of American adults have some form of heart disease. Patients with low income are at an even greater risk. The circular relation between depression and heart disease raises the question of whether or not there are factors that lead to both. Attacking a factor that affects both depression and heart disease could help prevent them both. One such factor is rumination which is when someone tends to have repeated negative thoughts that loop without end. This loop in turn tears and wears down the body over time, making the person be at risk for heart disease and depression. Rumination-Focused Cognitive Behavioral Therapy (RFCBT) is a tool that targets rumination and, by doing so, reduces the risk for depression. While research has shown RFCBT helps to reduce or stop the loop that leads to depression, this project will further look at the effect of RFCBT on measures of heart health persons with low income.


Description:

Objectives Objective #1: Determine whether RFCBT will impact blood pressure as a biomarker of cardiovascular health. The investigators hypothesize that RFCBT will lead to an improvement in blood pressure. Objective #2: Determine whether RFCBT will impact stress biomarkers of cardiovascular health. The investigators hypothesize that RF-CBT will lead to an improvement of salivary cortisol. Objective #3: Determine whether RFCBT will impact inflammatory biomarkers of cardiovascular health. The investigators hypothesize that RF-CBT will lead to an improvement of salivary C-Reactive Protein (h-CRP), interleukin (IL-6), and tumor necrosis factor-alpha (TNF-α). Objective #4: Determine the acceptability of RFCBT for individuals with low income. While the investigators cannot predict the themes that will be generated, the information will have implications for the use of RFCBT with individuals with low income. Study Design/Methodology The investigators will use a multiple baseline design - a type of Single Case Experimental Design (SCED) and collect survey, interview, and biological (blood pressure & saliva) data. Because of the study design, all participants will receive Rumination-Focused Cognitive Behavioral Training (RFCBT); the study is not blinded, and no non-intervention control group is necessary. As participants will be selected non-randomly, they will be randomly assigned to a group or in other words after how many weeks of baseline phase they will perceive RFCBT using the random number generator in the statistics package R. That is, 1/3rd of the participants will participate in 5 baseline waves of data collection, each one week apart, before starting RFCBT, another 1/3rd of participants will participate in 6 baseline waves before starting RFCBT, and the final 1/3rd of participants will participate in 6 baseline waves before starting RFCBT. Thus, all participants will participate in 5 to 7 weekly baseline waves. Next, each participant will participate with their trainer in up to 18 50-minute meetings of RFCBT. In this time, each participant will participate in 6 to 9 waves of training data collection (one wave of data collection every 2 RFCBT meetings). After completion of the training, each participant will be followed for another 10 weeks during which they participate in 5 waves of follow-up data collection (one wave of data collection every 2 weeks). Thus, each participant participates in 28 to 36 weeks in the study and takes part in 16 to 21 waves of data collection. The investigators plan to recruit 27 adults with low income who have an elevated Response Style Questionnaire (RSQ)-Brooding score (>= 11), Patient Health Questionnaire (PHQ)-9 score (10-20), and blood pressure (systolic blood pressure [SBP]/ diastolic blood pressure [DBP]: >= 120 and/or 80) - that Have A Heart Clinic personnel administers regularly - and speak fluent English. There are no other exclusion criteria including any medical or psychological treatment. Patients who fulfill the above listed inclusion criteria are referred by Have A Heart Clinic personnel to the research team. At each wave of data collection, the investigators will administer all the surveys listed in this report. All questions will be administered at each wave except for the questions about demographic information which will be asked during Baseline-1 only. To measure blood pressure, the investigators will use an oscillometric measurement device. To do so, a blood pressure cuff will be placed about an inch above the elbow crease. For reliability purposes, blood pressure will be measured three-times with about 1 minute time between the measures. To measure cortisol, h-CRP, IL-6, and TNF-α levels in saliva, participants will also be asked to provide saliva samples. Participants will be asked to avoid eating food or drinking caffeine for 3 hours prior to the saliva data collection in order to prepare for the saliva testing. Once after the participants finish the RFCBT, they will be invited to take part in a semi-structured interview to explore their experiences in and acceptability of the training. The investigators intend to do these interviews with all participants who begin RFCBT (i.e., defined as completing at least one 50-minute meeting with their trainer), including those who drop out of the training, in-person, by phone, or a secure video platform. The RFCBT exclusively addresses one possible mechanism underlying depression, rumination. In general, a participant and their trainer will identify when the participant ruminates in an unhelpful manner, what triggers the rumination, what function the rumination fulfills for the participant, and how the participant already does to stop ruminating. Building on this knowledge both together will change the environment to reduce the likelihood of the participant to ruminate, use consciously strategies to stop rumination when it occurs, and replace rumination by more helpful strategies. In the proposed single subject study, the participant and the trainer will meet in person or using a UofL approved video platform up to 18 times for 50-minutes. Plan for Analysis of Results Following the best practice guidelines of the What Works Clearinghouse Standards for SCEDs, the investigators will examine consistency, intervention effect, immediacy, and auto-correlations for rumination, depressive symptoms, blood pressure, cortisol, h-CRP, IL-6, and TNF-α. The investigators will use Bayesian unknown changepoint models to estimate the parameters and model the treatment effect. A mixed effects model will be used to model the hierarchical structure of the data. The dependent variables are rumination, depressive symptoms, blood pressure, cortisol, h-CRP, IL-6, and TNF-α. The independent variable is phase. Bayesian estimation will be used to address the small sample nature of the data. For these statistical analyses the investigators will use R and "Just Another Gibbs Sampler" (JAGS). The investigators will conduct semi-structured interviews and analyze data using thematic analysis to generate themes associated with the data. The statistical program Dedoose will be utilized to facilitate this process.


Recruitment information / eligibility

Status Recruiting
Enrollment 9
Est. completion date August 31, 2026
Est. primary completion date August 31, 2026
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - RSQ-Brooding score: >= 11 - PHQ-9 score: 10-20 - SBP: >= 120 and/or DBP: >= 80) - fluent in English Exclusion Criteria: - None besides the described inclusion criteria

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Rumination-Focused Cognitive Behavior Therapy
The RFCBT exclusively addresses one possible mechanism underlying depression, rumination. In general, a participant and their therapist will identify when the participant ruminates in an unhelpful manner, what triggers the rumination, what function the rumination fulfills for the participant, and how the participant already does to stop ruminating. Building on this knowledge both together will change the environment to reduce the likelihood of the participant to ruminate, use consciously strategies to stop rumination when it occurs, and replace rumination by more helpful strategies. In the proposed single subject study, the participant and the therapist will meet in person or using a UofL approved video platform up to 18 times for 50-minutes.

Locations

Country Name City State
United States Have a Heart clinic Louisville Kentucky

Sponsors (1)

Lead Sponsor Collaborator
University of Louisville

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Response Style Questionnaire sadness rumination, Score range: 5-20, higher score = more rumination Baseline 1
Primary Response Style Questionnaire sadness rumination, Score range: 5-20, higher score = more rumination 1 week after baseline 1
Primary Response Style Questionnaire sadness rumination, Score range: 5-20, higher score = more rumination 2 weeks after baseline 1
Primary Response Style Questionnaire sadness rumination, Score range: 5-20, higher score = more rumination 3 weeks after baseline 1
Primary Response Style Questionnaire sadness rumination, Score range: 5-20, higher score = more rumination 4 weeks after baseline 1
Primary Response Style Questionnaire sadness rumination, Score range: 5-20, higher score = more rumination 5 weeks after baseline 1
Primary Response Style Questionnaire sadness rumination, Score range: 5-20, higher score = more rumination 6 weeks after baseline 1
Primary Response Style Questionnaire sadness rumination, Score range: 5-20, higher score = more rumination 7 weeks after baseline 1
Primary Response Style Questionnaire sadness rumination, Score range: 5-20, higher score = more rumination 9 weeks after baseline 1
Primary Response Style Questionnaire sadness rumination, Score range: 5-20, higher score = more rumination 11 weeks after baseline 1
Primary Response Style Questionnaire sadness rumination, Score range: 5-20, higher score = more rumination 13 weeks after baseline 1
Primary Response Style Questionnaire sadness rumination, Score range: 5-20, higher score = more rumination 15 weeks after baseline 1
Primary Response Style Questionnaire sadness rumination, Score range: 5-20, higher score = more rumination 17 weeks after baseline 1
Primary Response Style Questionnaire sadness rumination, Score range: 5-20, higher score = more rumination 19 weeks after baseline 1
Primary Response Style Questionnaire sadness rumination, Score range: 5-20, higher score = more rumination 21 weeks after baseline 1
Primary Response Style Questionnaire sadness rumination, Score range: 5-20, higher score = more rumination 23 weeks after baseline 1
Primary Response Style Questionnaire sadness rumination, Score range: 5-20, higher score = more rumination 25 weeks after baseline 1
Primary Response Style Questionnaire sadness rumination, Score range: 5-20, higher score = more rumination 27 weeks after baseline 1
Primary Response Style Questionnaire sadness rumination, Score range: 5-20, higher score = more rumination 29 weeks after baseline 1
Primary Response Style Questionnaire sadness rumination, Score range: 5-20, higher score = more rumination 31 weeks after baseline 1
Primary Response Style Questionnaire sadness rumination, Score range: 5-20, higher score = more rumination 33 weeks after baseline 1
Primary Patient Health Questionnaire-9 depressive symptoms, Score range: 0-27, higher score = more depressive symptoms Baseline 1
Primary Patient Health Questionnaire-9 depressive symptoms, Score range: 0-27, higher score = more depressive symptoms 1 week after baseline 1
Primary Patient Health Questionnaire-9 depressive symptoms, Score range: 0-27, higher score = more depressive symptoms 2 weeks after baseline 1
Primary Patient Health Questionnaire-9 depressive symptoms, Score range: 0-27, higher score = more depressive symptoms 3 weeks after baseline 1
Primary Patient Health Questionnaire-9 depressive symptoms, Score range: 0-27, higher score = more depressive symptoms 4 weeks after baseline 1
Primary Patient Health Questionnaire-9 depressive symptoms, Score range: 0-27, higher score = more depressive symptoms 5 weeks after baseline 1
Primary Patient Health Questionnaire-9 depressive symptoms, Score range: 0-27, higher score = more depressive symptoms 6 weeks after baseline 1
Primary Patient Health Questionnaire-9 depressive symptoms, Score range: 0-27, higher score = more depressive symptoms 7 weeks after baseline 1
Primary Patient Health Questionnaire-9 depressive symptoms, Score range: 0-27, higher score = more depressive symptoms 9 weeks after baseline 1
Primary Patient Health Questionnaire-9 depressive symptoms, Score range: 0-27, higher score = more depressive symptoms 11 weeks after baseline 1
Primary Patient Health Questionnaire-9 depressive symptoms, Score range: 0-27, higher score = more depressive symptoms 13 weeks after baseline 1
Primary Patient Health Questionnaire-9 depressive symptoms, Score range: 0-27, higher score = more depressive symptoms 15 weeks after baseline 1
Primary Patient Health Questionnaire-9 depressive symptoms, Score range: 0-27, higher score = more depressive symptoms 17 weeks after baseline 1
Primary Patient Health Questionnaire-9 depressive symptoms, Score range: 0-27, higher score = more depressive symptoms 19 weeks after baseline 1
Primary Patient Health Questionnaire-9 depressive symptoms, Score range: 0-27, higher score = more depressive symptoms 21 weeks after baseline 1
Primary Patient Health Questionnaire-9 depressive symptoms, Score range: 0-27, higher score = more depressive symptoms 23 weeks after baseline 1
Primary Patient Health Questionnaire-9 depressive symptoms, Score range: 0-27, higher score = more depressive symptoms 25 weeks after baseline 1
Primary Patient Health Questionnaire-9 depressive symptoms, Score range: 0-27, higher score = more depressive symptoms 27 weeks after baseline 1
Primary Patient Health Questionnaire-9 depressive symptoms, Score range: 0-27, higher score = more depressive symptoms 29 weeks after baseline 1
Primary Patient Health Questionnaire-9 depressive symptoms, Score range: 0-27, higher score = more depressive symptoms 31 weeks after baseline 1
Primary Patient Health Questionnaire-9 depressive symptoms, Score range: 0-27, higher score = more depressive symptoms 33 weeks after baseline 1
Primary systolic blood pressure measures systolic blood pressure; score range: 0-200+, higher score = higher blood pressure Baseline 1
Primary systolic blood pressure measures systolic blood pressure; score range: 0-200+, higher score = higher blood pressure 1 week after baseline 1
Primary systolic blood pressure measures systolic blood pressure; score range: 0-200+, higher score = higher blood pressure 2 weeks after baseline 1
Primary systolic blood pressure measures systolic blood pressure; score range: 0-200+, higher score = higher blood pressure 3 weeks after baseline 1
Primary systolic blood pressure measures systolic blood pressure; score range: 0-200+, higher score = higher blood pressure 4 weeks after baseline 1
Primary systolic blood pressure measures systolic blood pressure; score range: 0-200+, higher score = higher blood pressure 5 weeks after baseline 1
Primary systolic blood pressure measures systolic blood pressure; score range: 0-200+, higher score = higher blood pressure 6 weeks after baseline 1
Primary systolic blood pressure measures systolic blood pressure; score range: 0-200+, higher score = higher blood pressure 7 weeks after baseline 1
Primary systolic blood pressure measures systolic blood pressure; score range: 0-200+, higher score = higher blood pressure 9 weeks after baseline 1
Primary systolic blood pressure measures systolic blood pressure; score range: 0-200+, higher score = higher blood pressure 11 weeks after baseline 1
Primary systolic blood pressure measures systolic blood pressure; score range: 0-200+, higher score = higher blood pressure 13 weeks after baseline 1
Primary systolic blood pressure measures systolic blood pressure; score range: 0-200+, higher score = higher blood pressure 15 weeks after baseline 1
Primary systolic blood pressure measures systolic blood pressure; score range: 0-200+, higher score = higher blood pressure 17 weeks after baseline 1
Primary systolic blood pressure measures systolic blood pressure; score range: 0-200+, higher score = higher blood pressure 19 weeks after baseline 1
Primary systolic blood pressure measures systolic blood pressure; score range: 0-200+, higher score = higher blood pressure 21 weeks after baseline 1
Primary systolic blood pressure measures systolic blood pressure; score range: 0-200+, higher score = higher blood pressure 23 weeks after baseline 1
Primary systolic blood pressure measures systolic blood pressure; score range: 0-200+, higher score = higher blood pressure 25 weeks after baseline 1
Primary systolic blood pressure measures systolic blood pressure; score range: 0-200+, higher score = higher blood pressure 27 weeks after baseline 1
Primary systolic blood pressure measures systolic blood pressure; score range: 0-200+, higher score = higher blood pressure 29 weeks after baseline 1
Primary systolic blood pressure measures systolic blood pressure; score range: 0-200+, higher score = higher blood pressure 31 weeks after baseline 1
Primary systolic blood pressure measures systolic blood pressure; score range: 0-200+, higher score = higher blood pressure 33 weeks after baseline 1
Primary diastolic blood pressure measures diastolic blood pressure; score range: 0-200+, higher score = higher blood pressure Baseline 1
Primary diastolic blood pressure measures diastolic blood pressure; score range: 0-200+, higher score = higher blood pressure 1 week after baseline 1
Primary diastolic blood pressure measures diastolic blood pressure; score range: 0-200+, higher score = higher blood pressure 2 weeks after baseline 1
Primary diastolic blood pressure measures diastolic blood pressure; score range: 0-200+, higher score = higher blood pressure 3 weeks after baseline 1
Primary diastolic blood pressure measures diastolic blood pressure; score range: 0-200+, higher score = higher blood pressure 4 weeks after baseline 1
Primary diastolic blood pressure measures diastolic blood pressure; score range: 0-200+, higher score = higher blood pressure 5 weeks after baseline 1
Primary diastolic blood pressure measures diastolic blood pressure; score range: 0-200+, higher score = higher blood pressure 6 weeks after baseline 1
Primary diastolic blood pressure measures diastolic blood pressure; score range: 0-200+, higher score = higher blood pressure 7 weeks after baseline 1
Primary diastolic blood pressure measures diastolic blood pressure; score range: 0-200+, higher score = higher blood pressure 9 weeks after baseline 1
Primary diastolic blood pressure measures diastolic blood pressure; score range: 0-200+, higher score = higher blood pressure 11 weeks after baseline 1
Primary diastolic blood pressure measures diastolic blood pressure; score range: 0-200+, higher score = higher blood pressure 13 weeks after baseline 1
Primary diastolic blood pressure measures diastolic blood pressure; score range: 0-200+, higher score = higher blood pressure 15 weeks after baseline 1
Primary diastolic blood pressure measures diastolic blood pressure; score range: 0-200+, higher score = higher blood pressure 17 weeks after baseline 1
Primary diastolic blood pressure measures diastolic blood pressure; score range: 0-200+, higher score = higher blood pressure 19 weeks after baseline 1
Primary diastolic blood pressure measures diastolic blood pressure; score range: 0-200+, higher score = higher blood pressure 21 weeks after baseline 1
Primary diastolic blood pressure measures diastolic blood pressure; score range: 0-200+, higher score = higher blood pressure 23 weeks after baseline 1
Primary diastolic blood pressure measures diastolic blood pressure; score range: 0-200+, higher score = higher blood pressure 25 weeks after baseline 1
Primary diastolic blood pressure measures diastolic blood pressure; score range: 0-200+, higher score = higher blood pressure 27 weeks after baseline 1
Primary diastolic blood pressure measures diastolic blood pressure; score range: 0-200+, higher score = higher blood pressure 29 weeks after baseline 1
Primary diastolic blood pressure measures diastolic blood pressure; score range: 0-200+, higher score = higher blood pressure 31 weeks after baseline 1
Primary diastolic blood pressure measures diastolic blood pressure; score range: 0-200+, higher score = higher blood pressure 33 weeks after baseline 1
See also
  Status Clinical Trial Phase
Completed NCT03255187 - Effect of Dietary Supplemental Fish Oil in Alleviating Health Hazards Associated With Air Pollution N/A
Completed NCT05997303 - Continuous Norepinephrine Administration and Blood Pressure Stability During Anesthetic Induction N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT03918486 - Caretaker vs. Routine Blood Pressure Sphygmomanometer
Completed NCT03410342 - The Effects of Types of Fruits and Vegetables on Vascular Function N/A
Active, not recruiting NCT05062161 - Sleep Duration and Blood Pressure During Sleep N/A
Not yet recruiting NCT04087070 - Blood Pressure Estimation Using Noninvasive Biosignals During Pediatric Anesthesia
Completed NCT03294928 - Arterial Waveform Analysis Applying Different Positive End-Expiratory Pressure (PEEP) Levels in Healthy Volunteers N/A
Completed NCT03859934 - Metabolic Effects of Melatonin Treatment Phase 1
Completed NCT03997461 - Comparison of Arterial Tonometry Sensor With Standard Oscillometric Blood Pressure Monitoring Device N/A
Completed NCT03290716 - Diet, ExerCIse and carDiovascular hEalth (DECIDE) - Salt Reduction Strategies for the Elderly in Nursing Homes in China N/A
Recruiting NCT06460233 - Blood Pressure Changes After Bariatric Surgery
Recruiting NCT05196048 - Blood Pressure Sensor of Watch-type Device With ECG Technology
Terminated NCT03325933 - Resistance Training and Cardiometabolic Health N/A
Not yet recruiting NCT06405880 - Pharmacist Case Finding and Intervention for Vascular Prevention Trial N/A
Completed NCT02924454 - Effects of Lipid Emulsion on the Pharmacokinetic and Pharmacodynamic Properties of Metoprolol. Phase 4
Completed NCT02451059 - Reducing Socioeconomic Disparities in Health at Pediatric Visits N/A
Active, not recruiting NCT02670967 - Effects of Soluble Fiber on Blood Pressure: A Meta-analysis of Randomly-controlled Trials N/A
Completed NCT02271633 - Nitrate Supplementation; Source Phase 4
Completed NCT02239744 - Intervention Study on the Health Impact of Air Filters in Chinese Adults N/A